MedTrace Logo

Visual Outcome After Vitrectomy With Subretinal tPA Injection

NCT05196139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2022-01-19

No results posted yet for this study

Summary

evaluate the safety of Eva surgical system

Conditions

  • Age-Related Macular Degeneration

Interventions

OTHER

retrospective study

vitrectomy performed in case of submacular bleeding

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Peter Stalmans, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-08-16
Completion
2021-08-16

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05196139 on ClinicalTrials.gov